2016 annual financial data
China SXT Pharmaceuticals 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was 4.91%.
Operating income was 209,140 USD and net income was 141,544 USD.
Operating cash flow was 182,472 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,718,605 USD
- Operating income
- 209,140 USD
- Net income
- 141,544 USD
- Operating cash flow
- 182,472 USD